inos Search Results


94
Miltenyi Biotec inos antibody
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Inos Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/iNOS+Antibody%2C+anti-mouse%2C+REAfinity/pm36388459-159-10-12
Average 94 stars, based on 1 article reviews
inos antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

86
Jackson Laboratory nos2
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Nos2, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/nos2/pm41764738-40-4-7
Average 86 stars, based on 1 article reviews
nos2 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

95
Novus Biologicals anti nos2 inos
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Anti Nos2 Inos, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/iNOS+Antibody+-+BSA+Free/pm31847700-257-9-10
Average 95 stars, based on 1 article reviews
anti nos2 inos - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

93
Elabscience Biotechnology protein assay kit
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Protein Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/Rat+NOS2%2FiNOS+(Nitric+Oxide+Synthase+2/pm35204140-81-24-27
Average 93 stars, based on 1 article reviews
protein assay kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
R&D Systems human total inos immunoassay enzymelinked immunosorbent assay elisa kit
Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. <t>ELISA-based</t> detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked <t>immunosorbent</t> assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.
Human Total Inos Immunoassay Enzymelinked Immunosorbent Assay Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/Human+iNOS+ELISA+Kit+(Colorimetric)/pm28911625-75-12-20
Average 93 stars, based on 1 article reviews
human total inos immunoassay enzymelinked immunosorbent assay elisa kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Novus Biologicals accessible kit
Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. <t>ELISA-based</t> detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked <t>immunosorbent</t> assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.
Accessible Kit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/Rat+iNOS+ELISA+Kit+(Colorimetric)/pm39869189-52-6-11
Average 93 stars, based on 1 article reviews
accessible kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Novus Biologicals mouse anti inos
Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. <t>ELISA-based</t> detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked <t>immunosorbent</t> assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.
Mouse Anti Inos, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/iNOS+Antibody+(M398)/pm30529726-46-0-9
Average 93 stars, based on 1 article reviews
mouse anti inos - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
Novus Biologicals anti inos pe
Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. <t>ELISA-based</t> detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked <t>immunosorbent</t> assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.
Anti Inos Pe, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/iNOS+Antibody+(4E5)+%5BPE%5D/pm33820854-54-18-19
Average 92 stars, based on 1 article reviews
anti inos pe - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

94
Elabscience Biotechnology mouse inos
Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. <t>ELISA-based</t> detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked <t>immunosorbent</t> assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.
Mouse Inos, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/Mouse+NOS2%2FiNOS+(Nitric+Oxide+Synthase+2/pmc12371823-49-6-9
Average 94 stars, based on 1 article reviews
mouse inos - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

95
R&D Systems inos
PAD4 inhibition reduces M1 macrophage polarization after tendon-bone injury. (a) Immunohistochemistry (IHC) analysis <t>of</t> <t>CD68</t> in tendon-bone section from control, TI, and TI + PAD4 inhibitor groups. (b) Quantification of CD11c positive cells. n = 6 mice/group. (c) IHC analysis of CD11c in tendon section from control, TI, and TI + PAD4 inhibitor groups. (d) Quantitative analysis of CD11c positive cells in c. n = 6 mice/group. (e) Western blot of <t>iNOS,</t> TLR4 and IL-1β in tendon tissue from control, TI, and TI + PAD4 inhibitor groups. (f) Quantification of relative gray intensity/GAPDH in c. n = 3 mice/group. Data are presented as the mean ± SEM. Scale bar = 1 mm. Significance was examined by one-way ANOVA (b, d, and f). ** P < 0.01, **** p < 0.0001.
Inos, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/Human%2FMouse%2FRat+iNOS+Antibody/pmc12365468-83-15-17
Average 95 stars, based on 1 article reviews
inos - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

96
Novus Biologicals anti inos rabbit
PAD4 inhibition reduces M1 macrophage polarization after tendon-bone injury. (a) Immunohistochemistry (IHC) analysis <t>of</t> <t>CD68</t> in tendon-bone section from control, TI, and TI + PAD4 inhibitor groups. (b) Quantification of CD11c positive cells. n = 6 mice/group. (c) IHC analysis of CD11c in tendon section from control, TI, and TI + PAD4 inhibitor groups. (d) Quantitative analysis of CD11c positive cells in c. n = 6 mice/group. (e) Western blot of <t>iNOS,</t> TLR4 and IL-1β in tendon tissue from control, TI, and TI + PAD4 inhibitor groups. (f) Quantification of relative gray intensity/GAPDH in c. n = 3 mice/group. Data are presented as the mean ± SEM. Scale bar = 1 mm. Significance was examined by one-way ANOVA (b, d, and f). ** P < 0.01, **** p < 0.0001.
Anti Inos Rabbit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/iNOS+Antibody+(3L0U6)/pmc06471825-123-0-2
Average 96 stars, based on 1 article reviews
anti inos rabbit - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

91
Novus Biologicals primary polyclonal rabbit anti inos antibody
Figure 2. Effects of chitosan oligosaccharideon on the phosphorylation level of NF-kB pathway, the protein expression level of nitric oxide synthase <t>(iNOS)</t> and interleukin-1b (IL-1b). Expressions of IL-1b(A); phosphorylated IjB kinase b (P-IKKb) (B); phosphorylated inhibitor of nuclear factor kappa-Ba (P-IjBa) (C); phosphorylated nuclear factor kappa-Bp65(P-NF-jBp65) (D); iNOS (E), protein levels were detected by western blotting and normalised to beta-actin (b-Actin) levels. CTR¼ control treatment, without chitosan oligosacchar- ides addition; COS40, COS80, COS160, and COS320¼ treated with 40, 80, 160, and 320lg/mL chitosan oligosaccharides respectively.
Primary Polyclonal Rabbit Anti Inos Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inos/iNOS+Antibody/10__1080_slash_1828051x__2020__1772131-67-9-15
Average 91 stars, based on 1 article reviews
primary polyclonal rabbit anti inos antibody - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

Image Search Results


Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the iNOS stained with the iNOS antibody conjugated with FITC.

Journal: Materials today. Bio

Article Title: Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy.

doi: 10.1016/j.mtbio.2022.100482

Figure Lengend Snippet: Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the iNOS stained with the iNOS antibody conjugated with FITC.

Article Snippet: After 30 min, the tissue slice was stained with diluted iNOS antibody (Miltenyi Biotec, catalog: 130-116-357) at 4 C overnight.

Techniques: Immunostaining, Immunohistochemistry, Staining

Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. ELISA-based detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked immunosorbent assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.

Journal: Journal of food and drug analysis

Article Title: Suppression of ERK1/2 and hypoxia pathways by four Phyllanthus species inhibits metastasis of human breast cancer cells.

doi: 10.1016/j.jfda.2016.03.010

Figure Lengend Snippet: Figure 2 e Protein-expression levels in (A) untreated cells and (B) representative images of cells treated with aqueous Phyllanthus watsonii. (C) Western blot showing VEGF expression in untreated cells and cells treated with extracts from the four Phyllanthus species. (d) Percentage of individual protein expression. (E, F) MMP expression in cells after treatment with aqueous and methanolic extracts from four Phyllanthus species, respectively. ELISA-based detection of (G) iNOS and (H) VEGF expression in untreated cells treated with extracts from the four Phyllanthus species. Error bars indicate the standard error of the mean of three independent experiments. p < 0.05 for each Phyllanthus treatment as compared with the untreated group. APN ¼ aqueous P. niruri; APU ¼ aqueous P. urinaria; APW ¼ aqueous P. watsonii; APA ¼ aqueous P. amarus; C ¼ untreated control; Cis ¼ cisplatin; Dox ¼ doxorubicin; ELISA ¼ enzyme-linked immunosorbent assay; H ¼ 500 mg/mL; I ¼ IC50 dosage; iNOS ¼ inducible nitric oxide synthase; L ¼ 50 mg/mL; M ¼ DNA marker; MMP ¼ matrix metalloproteinase; MPA ¼ methanolic P. amarus; MPN ¼ methanolic P. niruri; MPU ¼ methanolic P. urinaria; MPW ¼ methanolic P. watsonii; VEGF ¼ vascular endothelial growth factor.

Article Snippet: Total iNOS in the four Phyllanthus species-treated cells was measured using a human total-iNOS immunoassay enzymelinked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA) according to manufacturer instructions.

Techniques: Expressing, Western Blot, Enzyme-linked Immunosorbent Assay, Control, Marker

PAD4 inhibition reduces M1 macrophage polarization after tendon-bone injury. (a) Immunohistochemistry (IHC) analysis of CD68 in tendon-bone section from control, TI, and TI + PAD4 inhibitor groups. (b) Quantification of CD11c positive cells. n = 6 mice/group. (c) IHC analysis of CD11c in tendon section from control, TI, and TI + PAD4 inhibitor groups. (d) Quantitative analysis of CD11c positive cells in c. n = 6 mice/group. (e) Western blot of iNOS, TLR4 and IL-1β in tendon tissue from control, TI, and TI + PAD4 inhibitor groups. (f) Quantification of relative gray intensity/GAPDH in c. n = 3 mice/group. Data are presented as the mean ± SEM. Scale bar = 1 mm. Significance was examined by one-way ANOVA (b, d, and f). ** P < 0.01, **** p < 0.0001.

Journal: Journal of Tissue Engineering

Article Title: Formation of neutrophil extracellular traps in the early stages exacerbate the healing process by regulating macrophage polarization in Achilles tendon-bone injury

doi: 10.1177/20417314251348038

Figure Lengend Snippet: PAD4 inhibition reduces M1 macrophage polarization after tendon-bone injury. (a) Immunohistochemistry (IHC) analysis of CD68 in tendon-bone section from control, TI, and TI + PAD4 inhibitor groups. (b) Quantification of CD11c positive cells. n = 6 mice/group. (c) IHC analysis of CD11c in tendon section from control, TI, and TI + PAD4 inhibitor groups. (d) Quantitative analysis of CD11c positive cells in c. n = 6 mice/group. (e) Western blot of iNOS, TLR4 and IL-1β in tendon tissue from control, TI, and TI + PAD4 inhibitor groups. (f) Quantification of relative gray intensity/GAPDH in c. n = 3 mice/group. Data are presented as the mean ± SEM. Scale bar = 1 mm. Significance was examined by one-way ANOVA (b, d, and f). ** P < 0.01, **** p < 0.0001.

Article Snippet: For M1 macrophages detection, sections were incubated with CD68 (14-0681-82; Invitrogen), CD11c (14-0114-82, Invitrogen), and iNOS (MAB9502; R&D systems) antibodies.

Techniques: Inhibition, Immunohistochemistry, Control, Western Blot

Figure 2. Effects of chitosan oligosaccharideon on the phosphorylation level of NF-kB pathway, the protein expression level of nitric oxide synthase (iNOS) and interleukin-1b (IL-1b). Expressions of IL-1b(A); phosphorylated IjB kinase b (P-IKKb) (B); phosphorylated inhibitor of nuclear factor kappa-Ba (P-IjBa) (C); phosphorylated nuclear factor kappa-Bp65(P-NF-jBp65) (D); iNOS (E), protein levels were detected by western blotting and normalised to beta-actin (b-Actin) levels. CTR¼ control treatment, without chitosan oligosacchar- ides addition; COS40, COS80, COS160, and COS320¼ treated with 40, 80, 160, and 320lg/mL chitosan oligosaccharides respectively.

Journal: Italian Journal of Animal Science

Article Title: Protective effect of chitosan oligosaccharide against oxidative damage of peripheral blood mononuclear cells in dairy cows induced by diethylenetriamine/nitric oxide via NF-κB signalling pathway

doi: 10.1080/1828051x.2020.1772131

Figure Lengend Snippet: Figure 2. Effects of chitosan oligosaccharideon on the phosphorylation level of NF-kB pathway, the protein expression level of nitric oxide synthase (iNOS) and interleukin-1b (IL-1b). Expressions of IL-1b(A); phosphorylated IjB kinase b (P-IKKb) (B); phosphorylated inhibitor of nuclear factor kappa-Ba (P-IjBa) (C); phosphorylated nuclear factor kappa-Bp65(P-NF-jBp65) (D); iNOS (E), protein levels were detected by western blotting and normalised to beta-actin (b-Actin) levels. CTR¼ control treatment, without chitosan oligosacchar- ides addition; COS40, COS80, COS160, and COS320¼ treated with 40, 80, 160, and 320lg/mL chitosan oligosaccharides respectively.

Article Snippet: The membranes were incubated in the following primary antibodies: primary polyclonal rabbit anti-iNOS antibody (NBP1-97471, Novus Biological, USA), rabbit anti-IL-1b (Cell Signalling Technology, Boston, MA), anti-IKKb, monoclonal rat anti-IjBa, monoclonal rabbit anti-NF-jBp65 antibody(NF-jB pathway Sampler Kit 9963,CST, MA), anti-phospho-IKKb, anti-phospho-IjBa, and anti-phospho-NF-jBp65 (NF-jB pathway Sampler Kit 9963, CST, MA).

Techniques: Phospho-proteomics, Expressing, Western Blot, Control